Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma news

    Tag: pharma news

    You Searched For "pharma news"
    AbbVie says multiple parties vying for assets related to Allergan deal approval

    AbbVie says multiple parties vying for assets related to Allergan deal approval

    Medical Dialogues Bureau4 Nov 2019 9:00 AM IST
    AbbVie Inc said it had notified the U.S. antitrust watchdog of its intention to divest its experimental inflammatory bowel disease therapy,...
    Another delay in USD 2.1 million gene therapy Zolgensma data reporting, Novartis admits mistake

    Another delay in USD 2.1 million gene therapy Zolgensma data reporting, Novartis admits mistake

    Medical Dialogues Bureau3 Nov 2019 9:45 AM IST
    The USFDA on Wednesday placed a partial hold on a Novartis trial of the $2.1 million-per-patient gene therapy, Zolgensma after the company informed...
    Amgen to reduce price of its cholesterol drug Repatha starting 2020

    Amgen to reduce price of its cholesterol drug Repatha starting 2020

    Medical Dialogues Bureau3 Nov 2019 9:15 AM IST
    Amgen launched the lower-price option of Repatha last October, selling the drug to some patients under the list price of $5,850 per year because the...
    Bristol-Myers Opdivo, Yervoy show promise in lung cancer trial

    Bristol-Myers Opdivo, Yervoy show promise in lung cancer trial

    Medical Dialogues Bureau3 Nov 2019 9:00 AM IST
    Bristol-Myers Squibb said its therapies when administered alongside two courses of chemotherapy demonstrated superior overall survival compared to...
    Andhra Pradesh: Blast at Chemist shop, 2 dead

    Andhra Pradesh: Blast at Chemist shop, 2 dead

    Farhat Nasim2 Nov 2019 4:25 PM IST
    Though the cause of the fire is unknown, yet it is suspected that a blast in the AC compressor caused the incident. The cops found the dead body of...
    Tests indicate heartburn drug Zantac does not form carcinogen in users: USFDA

    Tests indicate heartburn drug Zantac does not form carcinogen in users: USFDA

    Medical Dialogues Bureau2 Nov 2019 9:30 AM IST
    Zantac sold over-the-counter in the United States by French drugmaker Sanofi SA, and some of its generic versions, have been recalled due to possible...
    Revenue from operations stood at Rs 2005 crore in Q2: Torrent Pharma

    Revenue from operations stood at Rs 2005 crore in Q2: Torrent Pharma

    Medical Dialogues Bureau2 Nov 2019 9:15 AM IST
    Consolidated revenue from operations stood at Rs 2,005 crore for the quarter under consideration as against Rs 1,894 crore for the same period last...
    Landmark: Sanofi announces to reduce price of TB drug Rifapentine by 70 percent

    Landmark: Sanofi announces to reduce price of TB drug Rifapentine by 70 percent

    Medical Dialogues Bureau1 Nov 2019 3:29 PM IST
    Scale-up of affordable Rifapentine stands to benefit over a million people in India alone, where more people suffer from TB than anywhere else in the...
    Cadila Healthcare gets EIR from USFDA for Baddi facility

    Cadila Healthcare gets EIR from USFDA for Baddi facility

    Medical Dialogues Bureau1 Nov 2019 2:11 PM IST
    New Delhi: Drug firm Cadila Healthcare on Thursday said its Baddi facility in Himachal Pradesh has received establishment inspection report (EIR) from...
    Iconic Crocin Pain Relief to get a relaunch

    Iconic Crocin Pain Relief to get a relaunch

    Garima1 Nov 2019 1:49 PM IST
    GSK markets five varients of Crocin namely Crocin Advance, Crocin 650 Mg, Crocin Pain Relief, Crocin Cold & Flu and Crocin's Children Range...
    Bayer Roundup suits increase to 42700

    Bayer Roundup suits increase to 42700

    Medical Dialogues Bureau1 Nov 2019 9:00 AM IST
    A court-appointed mediator between Bayer and US plaintiffs in August denied reports the company had offered an $8 billion settlement to get the cases...
    Merck loses bid to revive over Rs 18 crore patent verdict against Gilead

    Merck loses bid to revive over Rs 18 crore patent verdict against Gilead

    Farhat Nasim31 Oct 2019 3:27 PM IST
    In 2016, a jury returned a verdict that Gilead Science's hepatitis C drugs Sovaldi and Harvoni infringed the patent, which Merck acquired when it...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok